The evidence

Published evidence for low-dose radiotherapy

Insurers say there is not enough evidence for low-dose radiotherapy in benign conditions, or call it experimental. This page lists the published record, with a link to every source, so anyone can check it.

Summary

  • Long use. Doctors have treated painful joints with X-rays since at least 1898. Germany has followed national guidelines for radiotherapy of benign conditions since 1995, and German centers treat tens of thousands of these patients a year.
  • National guideline. Germany’s S2e guideline (version 3.0, 2022) recommends radiotherapy for painful plantar fasciitis at its highest grade (A) and for painful elbow at grade B. It lists knee, hip and hand osteoarthritis, shoulder pain and outer hip pain as conditions where it can be used (grade C).
  • Large patient series. Across tens of thousands of treated patients, studies report that roughly 60% to 90% have less pain, often for a year or longer, with few or no side effects reported.
  • Randomized trials. For heel pain, radiotherapy beat steroid injection in a randomized trial, and a standard dose beat a very low dose. For osteoarthritis, the randomized evidence is mixed: two small Dutch sham-controlled trials found no difference, while a 2025 trial in older patients found benefit. Both kinds of result are listed below.
  • US standards. In 2026 the American Radium Society published appropriate-use criteria for low-dose radiotherapy in osteoarthritis.

History and clinical guidelines

Radiotherapy for painful joints and tendons is not new. It has been used for well over a century and is covered by national treatment guidelines in Germany.

  1. X-rays and radium were first used clinically for non-cancerous conditions about 130 years ago, before many of their uses in cancer care.

    Condition: Non-cancerous conditions (general)Design: Historical reviewYear: 2026

    Micke O, Oertel M, Muecke R, Eich HT, Kriz J (2026). 130 Years of Radiotherapy for Nonmalignant Diseases: A Historical Overview. Semin Radiat Oncol. 2026;36:3-17. PMID 41391896. doi:10.1016/j.semradonc.2025.11.004

  2. Germany’s national guideline says radiotherapy should be performed for painful plantar fasciitis (evidence level 1b, grade A, its highest) and for painful elbow syndrome (grade B), and can be performed for knee, hip and small-joint osteoarthritis, painful shoulder and trochanteric bursitis (grade C). It records that Sokoloff reported X-ray treatment of painful joints in 1898.

    Condition: Osteoarthritis, enthesopathies and other benign conditionsDesign: National evidence-based clinical guideline (S2e)Year: 2022

    DEGRO Working Group “Radiotherapy of Benign Diseases” (coordinators: Mücke R, Micke O, Seegenschmiedt MH, Kriz J) (2022). Radiotherapy for benign diseases. Specialist group-specific evidence-based S2e guideline of the German Society for Radiation Oncology (DEGRO), Version 3.0. German Society for Radiation Oncology (DEGRO), 19 November 2022 (English translation).

  3. Low-dose radiotherapy for painful degenerative skeletal disorders is effective in most patients and is a reasonable option when simple non-invasive treatments have not worked; 3–6 Gy per course in 0.5–1.0 Gy sessions is recommended.

    Condition: Knee, hip, hand osteoarthritis; shoulder, hip bursitis, heel and elbow painDesign: Guideline summaryYear: 2015

    Ott OJ, Niewald M, Weitmann HD, et al.; German Cooperative Group on Radiotherapy for Benign Diseases (2015). DEGRO guidelines for the radiotherapy of non-malignant disorders. Part II: Painful degenerative skeletal disorders. Strahlenther Onkol. 2015;191(1):1-6. PMID 25238992. doi:10.1007/s00066-014-0757-3

  4. About 50,000 patients a year in Germany are referred for radiotherapy of non-malignant disorders, and German radiation oncologists have followed national consensus guidelines for this since 1995.

    Condition: Non-cancerous conditions (general)Design: Review of national practice guidelinesYear: 2015

    Seegenschmiedt MH, Micke O, Muecke R; German Cooperative Group on Radiotherapy for Non-malignant Diseases (2015). Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines. Br J Radiol. 2015;88(1051):20150080. PMID 25955230. doi:10.1259/bjr.20150080

  5. In 2014 the 116 German radiotherapy centers that answered treated 36,830 patients for benign diseases, including 14,936 for osteoarthritis and 10,510 for heel spur.

    Condition: Non-cancerous conditions (general)Design: National patterns-of-care surveySize: 116 institutions; 36,830 patientsYear: 2018

    Kriz J, Seegenschmiedt HM, Bartels A, et al. (2018). Updated strategies in the treatment of benign diseases—a patterns of care study of the German Cooperative Group on Benign Diseases. Adv Radiat Oncol. 2018;3(3):240-244. PMID 30197936. doi:10.1016/j.adro.2018.02.008

  6. Laboratory and animal studies confirm the anti-inflammatory effect of low-dose X-rays seen in patients; the guideline says radiation risk should be taken into account when treating benign disease.

    Condition: Mechanism and safetyDesign: Guideline summaryYear: 2015

    Reichl B, Block A, Schäfer U, et al.; German Cooperative Group on Radiotherapy for Benign Diseases (2015). DEGRO practical guidelines for radiotherapy of non-malignant disorders: Part I: physical principles, radiobiological mechanisms, and radiogenic risk. Strahlenther Onkol. 2015;191(9):701-9. PMID 26117368. doi:10.1007/s00066-015-0865-8

Reviews and pooled analyses

Studies that combine results across many trials and cohorts.

  1. A US panel of radiation oncologists, rheumatologists, orthopedic surgeons and a patient advocate found overall response rates of 60% to 90%, with less pain, better joint mobility and better quality of life; it calls for more high-quality studies.

    Condition: OsteoarthritisDesign: Systematic review and expert consensus (US appropriate-use criteria)Size: 52 studiesYear: 2026

    Dove A, Koneru B, Small W Jr, et al. (2026). American Radium Society (ARS) Appropriate Use Criteria (AUC) for Low-Dose Radiotherapy for Treatment of Osteoarthritis. Am J Clin Oncol. 2026 (online ahead of print, May 25). PMID 42184209. doi:10.1097/COC.0000000000001333

  2. Pooled response rates were 62–64% within 6 months and 69–85% at 12 months or later, with similar results for both types of X-ray equipment and no clinical side effects noted.

    Condition: Painful degenerative musculoskeletal diseasesDesign: Systematic review and meta-analysisSize: 33 studies; 12,143 patientsYear: 2025

    Kim A, Kwon J, Kim JY, Kim BH (2025). Comparative effectiveness of kilo- and megavoltage energies in low-dose radiotherapy for painful degenerative musculoskeletal diseases: a systematic review and meta-analysis. Strahlenther Onkol. 2025;201(5):483-494. PMID 39633160. doi:10.1007/s00066-024-02329-0

  3. Recent studies outside the US show moderate to long-term pain relief and better mobility; the authors describe low-dose radiotherapy as cost-effective and non-invasive with minimal side effects.

    Condition: OsteoarthritisDesign: Narrative reviewYear: 2022

    Dove APH, Cmelak A, Darrow K, et al. (2022). The Use of Low-Dose Radiation Therapy in Osteoarthritis: A Review. Int J Radiat Oncol Biol Phys. 2022;114(2):203-220. PMID 35504501. doi:10.1016/j.ijrobp.2022.04.029

Knee, hip and ankle osteoarthritis

  1. Patients who received 3 Gy had significant improvements in pain, knee function, performance status and painkiller use from the first month through six months, with no adverse effects.

    Condition: Knee osteoarthritisDesign: Randomized controlled trial (patients over 65)Year: 2025

    Fazilat-Panah D, Javadinia SA, Shabestani Monfared A, et al. (2025). Effects of low dose rate radiotherapy on pain relief, performance score, and quality of life in patients with knee osteoarthritis; a double-blind sham-controlled randomized clinical trial. Int J Radiat Biol. 2025;101(5):541-548. PMID 40043233. doi:10.1080/09553002.2025.2473975

  2. Average pain fell from 7.9 to 3.5 (0–10 scale) at four weeks and was still 4.0 at 12 months; 88 of 90 evaluable patients had at least 30% less pain, with no serious side effects.

    Condition: Advanced knee osteoarthritisDesign: Prospective single-arm studySize: 106 enrolled; 90 evaluableYear: 2026

    Ranja AG, Pal SK, Banerjee C, et al. (2026). Efficacy of Low-Dose Radiotherapy for Pain Control in Elderly Patients With Advanced Knee Osteoarthritis: A Prospective Single-Arm Study From India. Cureus. 2026;18(8):e115078. PMID 42781520. doi:10.7759/cureus.115078

  3. Pain went down at about two-thirds of treated joints, and patients aged 85 and older responded as well as those aged 65 to 74.

    Condition: Osteoarthritis in patients 65 and olderDesign: Retrospective multicenter cohortSize: 970 patients; 1,185 sitesYear: 2021

    Rühle A, Tkotsch E, Mravlag R, et al. (2021). Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites. Strahlenther Onkol. 2021;197(10):895-902. PMID 34342662. doi:10.1007/s00066-021-01816-y

  4. Across 5,069 evaluated cases, the median rate of pain reduction lasting at least three months was 60%, and no radiation side effects were observed.

    Condition: Knee osteoarthritisDesign: National patterns-of-care studySize: 5,069 evaluated casesYear: 2010

    Mücke R, Seegenschmiedt MH, Heyd R, et al. (2010). Radiotherapy in painful gonarthrosis. Results of a national patterns-of-care study [in German]. Strahlenther Onkol. 2010;186(1):7-17. PMID 20082182. doi:10.1007/s00066-009-1995-7

  5. 79.3% of treatment courses gave slight, marked or complete pain relief within two months, and more than half of those who responded had lasting improvement.

    Condition: Knee osteoarthritisDesign: Retrospective two-center cohortSize: 1,037 patientsYear: 2013

    Keller S, Müller K, Kortmann RD, et al. (2013). Efficacy of low-dose radiotherapy in painful gonarthritis: experiences from a retrospective East German bicenter study. Radiat Oncol. 2013;8:29. PMID 23369282. doi:10.1186/1748-717X-8-29

  6. Median pain fell from 7 to 3 (0–10 scale) at 12 and 24 months, and every subgroup had a significant reduction in pain.

    Condition: Osteoarthritis (mostly knee and finger)Design: Retrospective two-center cohortSize: 295 jointsYear: 2020

    Hautmann MG, Rechner P, Neumaier U, et al. (2020). Radiotherapy for osteoarthritis—an analysis of 295 joints treated with a linear accelerator. Strahlenther Onkol. 2020;196(8):715-724. PMID 31873780. doi:10.1007/s00066-019-01563-1

  7. About 58% of patients with hip osteoarthritis and 64% with greater trochanteric pain syndrome responded to treatment.

    Condition: Hip osteoarthritis and greater trochanteric pain syndromeDesign: Retrospective cohortYear: 2026

    Klepzig P, Nitsche M, Hermann RM, et al. (2026). Low-Dose External Beam Radiation Therapy and Painful Hip Due to Coxarthrosis and Greater Trochanteric Pain Syndrome: Predictive Impact of Diagnosis, Target Volume Definition, and Season of Treatment. Int J Radiat Oncol Biol Phys. 2026;125(3):772-782. PMID 41344607. doi:10.1016/j.ijrobp.2025.11.051

  8. Median pain fell from 7 to 4 at 12 months, joint mobility improved in 56.7% of cases, and no side effects were seen.

    Condition: Ankle and foot osteoarthritisDesign: Retrospective three-center cohortSize: 66 jointsYear: 2020

    Hautmann MG, Hipp M, Neumaier U, et al. (2020). Radiotherapy for osteoarthritis of the ankle and tarsal joints—analysis of 66 joints. Strahlenther Onkol. 2020;196(6):569-575. PMID 31784803. doi:10.1007/s00066-019-01551-5

Hand and finger osteoarthritis

  1. 70% of patients had less pain after treatment, and 0.5 Gy sessions gave better results than 1.0 Gy sessions.

    Condition: Finger and thumb osteoarthritisDesign: Retrospective cohortSize: 483 patientsYear: 2020

    Donaubauer AJ, Zhou JG, Ott OJ, et al. (2020). Low Dose Radiation Therapy, Particularly with 0.5 Gy, Improves Pain in Degenerative Joint Disease of the Fingers: Results of a Retrospective Analysis. Int J Mol Sci. 2020;21(16):5854. PMID 32824064. doi:10.3390/ijms21165854

  2. 94% reported less pain at a median follow-up of 10.5 months, 70 reported better function, and there were no acute or late complications.

    Condition: Hand osteoarthritisDesign: Prospective clinical protocol seriesSize: 100 patientsYear: 2022

    Álvarez B, Montero A, Alonso R, et al. (2022). Low-dose radiation therapy for hand osteoarthritis: shaking hands again?. Clin Transl Oncol. 2022;24(3):532-539. PMID 34585316. doi:10.1007/s12094-021-02710-w

  3. Median overall pain fell from 7 to 2 at 12 months and patient-rated hand function improved; grip strength did not change.

    Condition: Thumb-base osteoarthritisDesign: Prospective observational studySize: 25 patientsYear: 2021

    Hermann RM, Trillmann A, Becker JN, et al. (2021). Prospective Evaluation of Low-Dose External Beam Radiotherapy (LD-EBRT) for Painful Trapeziometacarpal Osteoarthritis (Rhizarthrosis) on Pain, Function, and Quality of Life to Calculate the Required Number of Patients for a Prospective Randomized Study. Med Sci (Basel). 2021;9(4):66. PMID 34842775. doi:10.3390/medsci9040066

Heel pain (plantar fasciitis, heel spur) and Achilles tendon pain

Heel pain has the strongest randomized evidence, including a trial against steroid injection and a trial against a very low dose.

  1. Radiotherapy gave significantly better pain and function scores than steroid injection at three months, and the advantage lasted at least six months.

    Condition: Plantar fasciitisDesign: Randomized controlled trial vs steroid injectionSize: 128 patientsYear: 2015

    Canyilmaz E, Canyilmaz F, Aynaci O, et al. (2015). Prospective Randomized Comparison of the Effectiveness of Radiation Therapy and Local Steroid Injection for the Treatment of Plantar Fasciitis. Int J Radiat Oncol Biol Phys. 2015;92(3):659-66. PMID 25936814. doi:10.1016/j.ijrobp.2015.02.009

  2. The standard 6 Gy dose was significantly better than a very low 0.6 Gy dose at three months, and the benefit held for at least one year.

    Condition: Plantar fasciitis / heel spurDesign: Randomized multicenter trial, standard vs very low doseSize: 66 patientsYear: 2012

    Niewald M, Seegenschmiedt MH, Micke O, et al. (2012). Randomized, multicenter trial on the effect of radiation therapy on plantar fasciitis (painful heel spur) comparing a standard dose with a very low dose: mature results after 12 months' follow-up. Int J Radiat Oncol Biol Phys. 2012;84(4):e455-62. PMID 22836057. doi:10.1016/j.ijrobp.2012.06.022

  3. Both 3 Gy and 6 Gy courses produced a highly significant reduction in symptoms at six months, with no difference between doses.

    Condition: Heel spurDesign: Randomized trial of two dosesSize: 130 patientsYear: 2007

    Heyd R, Tselis N, Ackermann H, et al. (2007). Radiation therapy for painful heel spurs: results of a prospective randomized study. Strahlenther Onkol. 2007;183(1):3-9. PMID 17225939. doi:10.1007/s00066-007-1589-1

  4. Both schedules gave good pain relief at 48 weeks, patients who needed a second course also benefited, and no relevant side effects were recorded.

    Condition: Heel spurDesign: Randomized multicenter trial of two schedulesSize: 127 patientsYear: 2017

    Prokein B, Holtmann H, Hautmann MG, et al. (2017). Radiotherapy of painful heel spur with two fractionation regimens: Results of a randomized multicenter trial after 48 weeks' follow-up. Strahlenther Onkol. 2017;193(6):483-490. PMID 28243722. doi:10.1007/s00066-017-1116-y

  5. 87% responded right after treatment and 95% at about 2.5 years, with 0.5 Gy and 1.0 Gy sessions working equally well.

    Condition: Heel pain (calcaneodynia)Design: Randomized dose-optimization trialSize: 457 patientsYear: 2014

    Ott OJ, Jeremias C, Gaipl US, et al. (2014). Radiotherapy for benign calcaneodynia: long-term results of the Erlangen Dose Optimization (EDO) trial. Strahlenther Onkol. 2014;190(7):671-5. PMID 24668250. doi:10.1007/s00066-014-0618-0

  6. Pain went down for at least three months in 70% of patients and stayed down in 65%, with no radiation side effects observed.

    Condition: Heel spur / plantar fasciitisDesign: National patterns-of-care studySize: 7,947 patientsYear: 2004

    Micke O, Seegenschmiedt MH; German Cooperative Group on Radiotherapy for Benign Diseases (2004). Radiotherapy in painful heel spurs (plantar fasciitis)—results of a national patterns of care study. Int J Radiat Oncol Biol Phys. 2004;58(3):828-43. PMID 14967440. doi:10.1016/S0360-3016(03)01620-1

  7. At a median of four years, 67% and 72% of heels in the two dose groups were completely free of pain; the authors recommend radiotherapy as a primary treatment, not a last resort.

    Condition: Heel spur, treatment-resistantDesign: Cohort comparing three dose schedulesSize: 141 patients; 170 heelsYear: 1996

    Seegenschmiedt MH, Keilholz L, Katalinic A, et al. (1996). Heel spur: radiation therapy for refractory pain—results with three treatment concepts. Radiology. 1996;200(1):271-6. PMID 8657925. doi:10.1148/radiology.200.1.8657925

  8. The authors found low-dose radiotherapy safe and effective with no clear radiation toxicity, and a second course gave good pain relief to 40% of those who needed one.

    Condition: Heel spurDesign: Retrospective cohort, up to 10-year follow-upSize: 666 patients; 864 heelsYear: 2021

    Rudat V, Tontcheva N, Kutz G, et al. (2021). Long-term effect and prognostic factors of a low-dose radiotherapy of painful plantar calcaneal spurs: A retrospective unicenter study. Strahlenther Onkol. 2021;197(10):876-884. PMID 33502569. doi:10.1007/s00066-020-01741-6

  9. 84% responded right after treatment and 95% at about two years.

    Condition: Achilles tendon painDesign: Randomized dose-optimization trialSize: 112 patientsYear: 2015

    Ott OJ, Jeremias C, Gaipl US, et al. (2015). Radiotherapy for benign achillodynia. Long-term results of the Erlangen Dose Optimization Trial. Strahlenther Onkol. 2015;191(12):979-84. PMID 26369640. doi:10.1007/s00066-015-0893-4

Elbow pain (epicondylitis)

  1. 80% responded right after treatment, 90% at six weeks and 94% at about three years.

    Condition: Painful elbow (epicondylitis)Design: Randomized dose-optimization trialSize: 199 patientsYear: 2014

    Ott OJ, Hertel S, Gaipl US, et al. (2014). The Erlangen Dose Optimization trial for low-dose radiotherapy of benign painful elbow syndrome. Long-term results. Strahlenther Onkol. 2014;190(3):293-7. PMID 24424629. doi:10.1007/s00066-013-0504-1

  2. Median pain fell from 7 to 0 at 12 and 24 months; 64.6% of patients scored 0 or 1 at 12 months, with no side effects.

    Condition: Epicondylitis (tennis and golfer’s elbow)Design: Retrospective two-center cohortSize: 138 elbowsYear: 2019

    Hautmann MG, Beyer LP, Süß C, et al. (2019). Radiotherapy of epicondylitis humeri: Analysis of 138 elbows treated with a linear accelerator. Strahlenther Onkol. 2019;195(4):343-351. PMID 30426149. doi:10.1007/s00066-018-1397-9

Shoulder pain

  1. 83% responded right after treatment and 82% at about three years.

    Condition: Painful shoulder syndromeDesign: Randomized dose-optimization trialSize: 312 patientsYear: 2014

    Ott OJ, Hertel S, Gaipl US, et al. (2014). The Erlangen Dose Optimization Trial for radiotherapy of benign painful shoulder syndrome. Long-term results. Strahlenther Onkol. 2014;190(4):394-8. PMID 24638241. doi:10.1007/s00066-013-0520-1

  2. Pain relief was achieved in 94 of 115 shoulders (82%) at a median of 18 months.

    Condition: Painful shoulder, including calcific tendinitisDesign: Prospective cohort with ultrasoundSize: 102 patients; 115 shouldersYear: 2010

    Adamietz B, Schulz-Wendtland R, Alibek S, et al. (2010). Calcifying tendonitis of the shoulder joint: predictive value of pretreatment sonography for the response to low-dose radiotherapy. Strahlenther Onkol. 2010;186(1):18-23. PMID 20082183. doi:10.1007/s00066-009-2025-5

Outer hip pain (greater trochanteric pain syndrome)

  1. Average pain fell from 8 to 4 at four months, and the estimated chance of keeping the pain relief was 53% at five years.

    Condition: Greater trochanteric pain syndrome (outer hip pain)Design: Prospective studySize: 155 patientsYear: 2022

    Biete A, Valduvieco I, Cases C, et al. (2022). Analgesic effects of low-dose radiotherapy in greater trochanteric pain syndrome: results in a clinical series of 155 patients with recurrent or refractory symptoms. Clin Transl Oncol. 2022;24(5):846-853. PMID 34807401. doi:10.1007/s12094-021-02730-6

  2. Three months after treatment, two-thirds of patients reported partial or complete relief.

    Condition: Greater trochanteric pain syndromeDesign: Retrospective cohortSize: 60 patients; 74 hipsYear: 2017

    Kaltenborn A, Carl UM, Hinsche T, et al. (2017). Low-dose external beam radiotherapy for greater trochanteric pain syndrome: Target volume definition and treatment outcome. Strahlenther Onkol. 2017;193(4):260-268. PMID 27837208. doi:10.1007/s00066-016-1071-z

  3. 59% had a good response two months after treatment, rising to 72.5% among hips that received two courses.

    Condition: Greater trochanteric pain syndromeDesign: Retrospective single-center cohortSize: 65 patients; 71 hipsYear: 2024

    Staruch M, Gomez S, Rogers S, et al. (2024). Low-dose radiotherapy for greater trochanteric pain syndrome—a single-centre analysis. Strahlenther Onkol. 2024;200(2):128-133. PMID 37580573. doi:10.1007/s00066-023-02107-4

Several conditions in one study

  1. Good responses rose from 37.6% at the end of treatment to 58.4% at a median of 33 months; knee patients did not improve further over time.

    Condition: Heel, Achilles, knee, hip bursitis and shoulder painDesign: Prospective multicenter quality assessmentSize: 703 patientsYear: 2018

    Micke O, Ugrak E, Bartmann S, et al. (2018). Radiotherapy for calcaneodynia, achillodynia, painful gonarthrosis, bursitis trochanterica, and painful shoulder syndrome—Early and late results of a prospective clinical quality assessment. Radiat Oncol. 2018;13(1):71. PMID 29673383. doi:10.1186/s13014-018-1025-y

Trials with negative or mixed results

These are the studies insurers and critics cite most often. We list them so readers can see the whole record.

  1. At three months, 44% of treated patients and 43% of sham patients responded; the authors found no meaningful benefit over sham.

    Condition: Knee osteoarthritisDesign: Randomized, double-blind, sham-controlled trial (Netherlands)Size: 55 patientsYear: 2019

    Mahler EAM, Minten MJ, Leseman-Hoogenboom MM, et al. (2019). Effectiveness of low-dose radiation therapy on symptoms in patients with knee osteoarthritis: a randomised, double-blinded, sham-controlled trial. Ann Rheum Dis. 2019;78(1):83-90. PMID 30366945. doi:10.1136/annrheumdis-2018-214104

  2. At three months, 29% of treated patients and 36% of sham patients responded; the difference was not significant.

    Condition: Hand osteoarthritisDesign: Randomized, blinded, sham-controlled trial (Netherlands)Size: 56 patientsYear: 2018

    Minten MJM, Leseman-Hoogenboom MM, Kloppenburg M, et al. (2018). Lack of beneficial effects of low-dose radiation therapy on hand osteoarthritis symptoms and inflammation: a randomised, blinded, sham-controlled trial. Osteoarthritis Cartilage. 2018;26(10):1283-1290. PMID 30231990. doi:10.1016/j.joca.2018.06.010

  3. No significant difference from sham was found at 6 or 12 months in either trial.

    Condition: Knee and hand osteoarthritisDesign: 12-month follow-up of the two Dutch trials aboveSize: 111 patients (55 knee, 56 hand)Year: 2020

    van den Ende CHM, Minten MJM, Leseman-Hoogenboom MM, et al. (2020). Long-term efficacy of low-dose radiation therapy on symptoms in patients with knee and hand osteoarthritis: follow-up results of two parallel randomised, sham-controlled trials. Lancet Rheumatol. 2020;2(1):e42-e49. PMID 38258275. doi:10.1016/S2665-9913(19)30096-7

  4. Pooling the sham-controlled trials, the authors found no significant benefit over sham for pain or function and more nail reactions after radiotherapy.

    Condition: OsteoarthritisDesign: Systematic review and meta-analysisSize: 12 studies; 1,750 participantsYear: 2025

    Hammadeh BM, Aldalati AY, Al Matairi A, et al. (2025). Efficacy, safety, and pain management of low-dose radiation therapy in osteoarthritis: a comprehensive systematic review and meta-analysis. Rheumatol Int. 2025;45(9):210. PMID 40888940. doi:10.1007/s00296-025-05942-z

  5. Pain improved in both dose groups at 12 months with no significant difference between them and no side effects; the authors say the effect of very low doses on pain is unknown.

    Condition: Knee and hand osteoarthritisDesign: Randomized single-blind trial, 3.0 Gy vs 0.3 GySize: 236 joints randomized (64 knees, 172 hands)Year: 2024

    Niewald M, Moumeniahangar S, Müller LN, et al. (2024). ArthroRad trial: randomized multicenter single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis—final results after 12-month follow-up. Strahlenther Onkol. 2024;200(2):134-142. PMID 37815599. doi:10.1007/s00066-023-02152-z

How to read these results:

  • The two Dutch trials each enrolled about 55 patients and used six sessions of 1 Gy. German radiation oncologists published a response disputing their conclusions (Ott OJ, Micke O, Mücke R, et al. “Low-dose radiotherapy: Mayday, mayday. We’ve been hit!” Strahlenther Onkol. 2019;195(4):285-288, PMID 30564845).
  • A 2025 randomized trial in patients over 65 (Fazilat-Panah et al., listed above) reported benefit.
  • Larger sham-controlled trials have been designed, including LoRD-KNeA in Korea (protocol, PMID 36764712) and KORT in Germany (protocol, PMID 41859527).

Insurer policies referenced on this site

  • EviCore by Evernorth, Radiation Oncology Guidelines V3.0.2026 for Cigna, effective November 5, 2026: osteoarthritis and plantar fasciitis are listed as “not medically necessary.” PDF
  • Blue Shield of California, medical policy “Low-Dose Radiotherapy for Non-Oncologic Indications”: “considered investigational for the treatment of osteoarthritis” and for plantar fasciitis. PDF
  • BlueCross BlueShield of Tennessee, “Low-Dose Radiotherapy for Non-Oncologic Indications”: osteoarthritis and plantar fasciitis “considered investigational.” Policy page

This page summarizes published research for public information. It is not medical advice. Findings are taken from each paper’s abstract or, for the German guideline, from the guideline text. Last checked October 2026.